Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04859660
Study type Interventional
Source University of Arizona
Contact M Gabra, MD
Phone 520-626-6636
Email [email protected]
Status Recruiting
Phase Phase 2
Start date April 16, 2021
Completion date June 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04010656 - Optimization of Spontaneous Postoperative Trial of Void Among Women N/A
Recruiting NCT03818321 - Urinary Track Infection Prevention After Urogynecological Surgery Phase 2
Not yet recruiting NCT04707001 - Urinary Retention After Arthroplasty N/A
Not yet recruiting NCT04597372 - Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery Phase 2
Completed NCT03071211 - Catheter Management After Pelvic Reconstructive Surgery N/A
Recruiting NCT04783012 - Patient Removal of Catheters After Urogynecologic Surgery N/A
Recruiting NCT04465578 - Incidence of Short-term Urinary Retention After Fascial Retropubic Sling: Prospective and Randomized Analysis. N/A
Completed NCT03065075 - Effect of Phenazopyridine on Prolapse Surgery Voiding Trials Phase 3
Recruiting NCT03808155 - Prevention of Postoperative Urinary Retention With Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty Phase 4